Evidence map›Paper›PMID 35729368›Full record

ArticleJournal of neuro-oncology2022

Stereotactic radiosurgery ensures an effective and safe long-term control of Koos grade IV vestibular schwannomas: a single-center, retrospective, cohort study.

Motoyuki Umekawa, Yuki Shinya, Hirotaka Hasegawa, Mariko Kawashima, Masahiro Shin, Atsuto Katano, Masanari Minamitani, Akinori Kashio, Kenji Kondo, Nobuhito Saito

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Motoyuki UmekawaDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.ORCID http://orcid.org/0000-0002-7722-9861
Yuki ShinyaDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo, 113-8655, Japan. yukishinya6155@gmail.com.ORCID http://orcid.org/0000-0003-0097-5804
Hirotaka HasegawaDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.ORCID http://orcid.org/0000-0002-3585-2188
Mariko KawashimaDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.ORCID http://orcid.org/0000-0002-8337-5945
Masahiro ShinDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.ORCID http://orcid.org/0000-0001-8025-127X
Atsuto KatanoDepartment of Radiology, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.ORCID http://orcid.org/0000-0003-4393-1828
Masanari MinamitaniDepartment of Radiology, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.ORCID http://orcid.org/0000-0002-8851-5695
Akinori KashioDepartment of Otorhinolaryngology, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.ORCID http://orcid.org/0000-0001-9453-9813
Kenji KondoDepartment of Otorhinolaryngology, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.ORCID http://orcid.org/0000-0002-0496-5067
Nobuhito SaitoDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.ORCID http://orcid.org/0000-0001-9756-781X

Funding

Japan Society for the Promotion of Science 20K17919
6 · The paper itself

Abstract

purposeStereotactic radiosurgery (SRS) is a standard treatment modality for vestibular schwannomas (VSs). However, there is a paucity of data on tumor control and neurological preservation for larger VSs. We aimed to investigate the long-term effectiveness of SRS for Koos grade IV compared with I-III VSs.

methodsWe included 452 patients with VSs (50 Koos grade IV and 402 Koos grade I‒III) who were treated with SRS at our institution from 1990 to 2021. Tumor control and functional preservation were calculated using the Kaplan-Meier method and compared between groups with the log-rank test.

resultsThe median post-SRS follow-up period was 68 months. Progression-free survival rates were 91% at 5 and 10 years for Koos grade IV VSs, and 95% and 92%, respectively, for Koos grade I‒III VSs (p = 0.278). In Koos grade IV VSs, functional preservation rates of the facial and trigeminal nerves were both 96% at 5 years (both 98% for Koos grade I‒III VSs; facial, p = 0.410; trigeminal, p = 0.107). Hearing preservation rates were 61% at 5 years for Koos grade IV VSs and 78% for Koos grade I-III VSs (p = 0.645). Symptomatic transient tumor expansion was more common with Koos grade IV VSs (8.0% vs. 2.5%, p = 0.034), although all related symptoms diminished in accordance with tumor shrinkage.

conclusionSRS may contribute to long-term tumor control and adequate neurological preservation in the treatment of Koos grade IV VSs, comparable to those in the treatment of Koos grade I‒III VSs.

Indexed as

Neuroma, AcousticRadiosurgeryCohort StudiesFollow-Up StudiesHumansRetrospective StudiesTreatment OutcomeGamma Knife radiosurgeryKoos grade IVStereotactic radiosurgeryVestibular schwannomas

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.